Moody’s downgrades Lafayette General Medical Center’s rating

Moody’s Investors Service has downgraded Lafayette (La.) General Medical Center’s rating to “Baa1” from “A3” and assigned a “Baa1” rating to its proposed $101 million of series 2016A and 2016B revenue bonds.

Advertisement

The rating downgrade is based on several factors, including LGHS’ balance sheet metrics that are no longer appropriate for the “A3” rating.

The outlook is stable, reflecting Moody’s expectation that its new capacity and management initiatives will enable LGHS to generate adequate cash flow to improve balance sheet metrics.

More articles on healthcare finance:
CDC: Americans getting better at paying medical bills
Prodigo Solutions to help Novation clients reduce supply chain costs
Is consumer-driven healthcare just a myth?

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.